Teva is based in Israel, but its Americas division headquarters is in North Wales.
The FDA said its preliminary lab tests revealed that the counterfeit version of Teva’s Adderall 30-mg tablets contained the wrong active ingredients. The correct version of Adderall contains four active ingredients: dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate. The FDA said the fake versions, instead of those active ingredients, contained tramadol and acetaminophen, which are ingredients to treat acute pain.
Adderall is currently on the FDA’s drug shortage list because of active ingredient supply issues. The FDA said consumers should be wary of online sources. "Rogue websites and distributors may especially target medicines in short supply for counterfeiting," the FDA statement said.
The FDA said that Teva’s authentic Adderall 30 mg tablets are round, orange/peach in color, and have "dp" embossed on one side and "30" on the other side of the tablet. Teva’s Adderall 30 mg tablets are packaged only in a 100-count bottle with the National Drug Code (NDC) 0555-0768-02 listed.
If the pills don’t look like that or they come in a blister pack, they should be considered fake.
Teva spokeswoman Denise Bradley said by e-mail that the company learned of two examples.
"Both were purchased from illegal websites, not through legitimate distribution channels," Bradley said. "We have reported to the FDA and continue to work with them on the investigation. We were alerted by a consumer who noticed misspellings on the fake product packaging. Our product is packaged in bottles. These fake product are packaged in foil wrappers."
The FDA asked consumers who think they received a counterfeit Adderall to contact the FDA’s Office of Criminal Investigations (OCI) at 800-551-3989.
Contact David Sell at 215-854-4506 or email@example.com, or @PhillyPharma on Twitter. Read his PhillyPharma blog on philly.com.